Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
Massimo Mattioli, Devis Benfaremo, Mauro Mancini, Luciano Mucci, Paola Mainquà, Antonio Polenta, Patrizia Maria Baldini, Francesca Fulgenzi, Donatella Dennetta, Samuele Bedetta, Lorenzo Gasperoni, A. Caraffa, G Frausini
Topics & Concepts
MedicineCoagulopathyPneumoniaLow molecular weight heparinInternal medicinePulmonary embolismHeparinHematologyGastroenterologySurgeryCOVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementLong-Term Effects of COVID-19